J. Scott Garland Insider Trading $PTLA PORTOLA PHARMACEUTICALS INC
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for J. Scott Garland.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of J. Scott Garland. J. Scott Garland is EVP & Chief Commerical Officer in EXELIXIS, INC. ($EXEL) and President and CEO in PORTOLA PHARMACEUTICALS INC ($PTLA) and SVP & Chief Commercial Officer in Relypsa Inc ($RLYP) and Director in Calithera Biosciences, Inc. ($CALA) and Director in Karyopharm Therapeutics Inc. ($KPTI).
J. Scott Garland in PORTOLA PHARMACEUTICALS INC
Trading Symbol: PTLAIndustry: PHARMACEUTICAL PREPARATIONS [2834]
Position of J. Scott Garland: President and CEO
Holdings: 0 shares
Current Value: $0
Latest Transaction: Jul 02 2020
$PTLA Market Capitalization: $1.55B
$PTLA Previous Close: $28.28
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of J. Scott Garland in PORTOLA PHARMACEUTICALS INC
1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
---|---|---|---|---|---|---|---|
No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, CALA, EXEL, KPTI, PTLA, RLYP
Page: 1
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Jul 02 2020 | PTLA | PORTOLA PHARMACEUT ... | Garland J. Scott | President and CEO | Option Exercise | D | 0.00 | 153,399 | 0 | 0 | |
Jul 02 2020 | PTLA | PORTOLA PHARMACEUT ... | Garland J. Scott | President and CEO | Option Exercise | D | 0.00 | 370,400 | 0 | 0 | |
Jul 02 2020 | PTLA | PORTOLA PHARMACEUT ... | Garland J. Scott | President and CEO | Option Exercise | D | 12.79 | 100,000 | 1,279,000 | 0 | |
Jul 02 2020 | PTLA | PORTOLA PHARMACEUT ... | Garland J. Scott | President and CEO | Option Exercise | D | 12.79 | 200,000 | 2,558,000 | 0 | |
Jul 02 2020 | PTLA | PORTOLA PHARMACEUT ... | Garland J. Scott | President and CEO | Option Exercise | D | 0.00 | 50,000 | 0 | 0 | |
Jul 02 2020 | PTLA | PORTOLA PHARMACEUT ... | Garland J. Scott | President and CEO | Option Exercise | D | 0.00 | 100,000 | 0 | 0 | |
Jul 02 2020 | PTLA | PORTOLA PHARMACEUT ... | Garland J. Scott | President and CEO | Sell | D | 18.00 | 1,173 | 21,114 | 0 | 1.2 K to 0 (-100.00 %) |
Jul 02 2020 | PTLA | PORTOLA PHARMACEUT ... | Garland J. Scott | President and CEO | Grant | A | 8.36 | 1,173 | 9,806 | 1,173 | 0 to 1.2 K |
Jul 02 2020 | PTLA | PORTOLA PHARMACEUT ... | Garland J. Scott | President and CEO | Sell | D | 18.00 | 24,529 | 441,522 | 0 | 24.5 K to 0 (-100.00 %) |
Feb 26 2020 | PTLA | PORTOLA PHARMACEUT ... | Garland J. Scott | President and CEO | Option Exercise | A | 0.00 | 150,000 | 0 | 150,000 | |
Feb 04 2020 | PTLA | PORTOLA PHARMACEUT ... | Garland J. Scott | President and CEO | Option Exercise | A | 12.79 | 200,000 | 2,558,000 | 200,000 | |
Feb 04 2020 | PTLA | PORTOLA PHARMACEUT ... | Garland J. Scott | President and CEO | Payment of Exercise | F | 12.89 | 5,623 | 72,480 | 177,928 | 183.6 K to 177.9 K (-3.06 %) |
Feb 04 2020 | PTLA | PORTOLA PHARMACEUT ... | Garland J. Scott | President and CEO | Grant | A | 0.00 | 50,000 | 0 | 183,551 | 133.6 K to 183.6 K (+37.44 %) |
Nov 04 2019 | PTLA | PORTOLA PHARMACEUT ... | Garland J. Scott | President and CEO | Payment of Exercise | F | 29.84 | 21,549 | 643,022 | 133,551 | 155.1 K to 133.6 K (-13.89 %) |
Feb 04 2019 | PTLA | PORTOLA PHARMACEUT ... | Garland J. Scott | President and CEO | Option Exercise | A | 27.10 | 120,400 | 3,262,840 | 120,400 | |
Feb 04 2019 | PTLA | PORTOLA PHARMACEUT ... | Garland J. Scott | President and CEO | Grant | A | 0.00 | 30,100 | 0 | 155,100 | 125 K to 155.1 K (+24.08 %) |
Oct 31 2018 | PTLA | PORTOLA PHARMACEUT ... | Garland J. Scott | President and CEO | Option Exercise | A | 19.69 | 250,000 | 4,922,500 | 250,000 | |
Oct 31 2018 | PTLA | PORTOLA PHARMACEUT ... | Garland J. Scott | President and CEO | Grant | A | 0.00 | 125,000 | 0 | 125,000 | 0 to 125 K |
Page: 1